Reported Q: Q4 2024 Rev YoY: +6.0% EPS YoY: +7.1% Move: +1.21%
CME Group Inc
CME
$285.35 1.21%
Exchange NASDAQ Sector Financial Services Industry Financial Data Stock Exchanges
Q4 2024
Published: Feb 27, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for CME

Reported

Report Date

Feb 27, 2025

Quarter Q4 2024

Revenue

1.53B

YoY: +6.0%

EPS

2.40

YoY: +7.1%

Market Move

+1.21%

Previous quarter: Q3 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $1.53B up 6% year-over-year
  • EPS of $2.40 increased by 7.1% from previous year
  • Gross margin of 85.5%
  • Net income of 874.60M
  • "“2024 was the best year in CME Group's history and our fourth consecutive year of record volume.”" - Terry Duffy
CME
Company CME

Swipe to view all report sections

Executive Summary

CME Group delivered a robust FY2024 characterized by a third consecutive year of record revenue and earnings, underpinned by broad-based volume growth across all six asset classes and an acceleration in commodities with notable gains in metals, energy, and agricultural products. In Q4 2024, CME generated $1.525 billion in revenue, up 6% year over year on similar volumes, driven by a 9% rise in market data revenue to $182 million. For the full year, revenue reached $6.1 billion, up 10% vs. 2023, and adjusted operating margin expanded to 68.3%, contributing to $3.7 billion of adjusted net income and 10% adjusted EPS growth. Management signaled meaningful 2025 targets, including higher overall operating expenses (approx. $1.65B, inclusive of cloud migration), capex of around $90 million, and an adjusted tax rate of 22.5%–23.5%. The company also outlined the anticipated impact of December-fee changes (roughly 1–1.5% higher futures/options revenue) and a 10-bp collateral surcharge for non-cash margin posts, with potential 2%–2.5% pre-tax income uplift depending on client behavior. A strategic emphasis on retail and new client acquisition, continued emphasis on data and technology, and expansion opportunities in securities clearing, weather/climate risk products, and crypto-related offerings frame CME’s longer-term trajectory. The company’s balance sheet remains strong with substantial liquidity, conservative leverage, and robust operating cash flow, supporting ongoing buybacks and a progressive dividend policy.

Key Performance Indicators

Revenue
Increasing
1.53B
QoQ: -3.73% | YoY: 5.98%
Gross Profit
Increasing
1.30B
85.52% margin
QoQ: -4.47% | YoY: 6.37%
Operating Income
Increasing
947.10M
QoQ: -7.53% | YoY: 9.72%
Net Income
Increasing
874.60M
QoQ: -4.18% | YoY: 7.37%
EPS
Increasing
2.40
QoQ: -4.38% | YoY: 7.14%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 1,880.10 3.18 +22.7% View
Q1 2025 1,642.30 2.62 +10.4% View
Q4 2024 1,525.30 2.40 +6.0% View
Q3 2024 1,584.40 2.50 +18.4% View
Q2 2024 1,532.50 2.42 +12.7% View